News and Announcements
4Dx to Close Capital Raise
- Published November 22, 2016 5:03PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
4Dx Limited is pleased to announce that due to an overwhelming response, as of 5pm AEDT, Friday, 9 December, 2016, the Company’s $4m Series A capital round will be officially closed. It is anticipated that the round will close oversubscribed.
4Dx is extremely pleased with the response to our capital raise with the domestic investment community demonstrating a deep understanding of our proposition, and the value inherent in it.
This result indicates a very clear acceptance of the need for 21st century diagnostic technology in the medical marketplace. The enthusiastic reception 4Dx has received delivers 4Dx a broad base of investors and makes us highly optimistic about the prospects of a second round of capital raising in early 2017.
Funds from the Series A investment round will be used to take the company’s first software product to market, including clinical studies to further validate the product and the entire 4DXV technology platform. Funds will also be used for the development and submission of its first application for U.S. Food and Drug Administration (FDA) clearance.
Major news media has picked up on the terrific progress being made by 4Dx, including an article published in The Australian newspaper’s Business Review section on 14 November 2016, and an article published in the Australian Financial Review on 21 November 2016.